On the other hand, some studies suggest that IDH1 and IDH2 mutations could contribute to progression from MDS or MPN to AML, through a mechanism of reactive oxygen species (ROS) accumulation and DNA damage leading to stabilization and activation of HIF-1 [29,30,31]. The gene discussed is IDH2; the disease is acute myeloid leukemia.